









Markets
/
Stocks
/
nasdaq-sbfmw
/

Sunshine Biopharma Inc

SBFMW

View Detailed Chart

0.210USD

-0.010-4.50%

Close 08/01, 16:00（ET）Quotes delayed by 15 min

0.00Market Cap

--P/E TTM



Sunshine Biopharma Inc

0.210

-0.010-4.50%

Overview Company Financials

Financials

Intraday

30m

Today

-4.50%

5 Days

-7.81%

1 Month

+Infinity%

6 Months

-25.00%

Year to Date

+30.52%

1 Year

+152.71%

View Detailed Chart

Agency Rating

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

15m

30m

15m

30m

D

Neutral

Sell(5)

Neutral(1)

Buy(6)

Indicators

Sell(5)

Neutral(1)

Buy(0)

Indicators

Value

Direction

MACD(12,26,9)

-0.024

Sell

RSI(14)

43.426

Neutral

STOCH(KDJ)(9,3,3)

40.000

Sell

ATR(14)

0.108

High Vlolatility

CCI(14)

-155.556

Sell

Williams %R

100.000

Oversold

TRIX(12,20)

-1.339

Sell

StochRSI(14)

5.119

Sell

Moving Average

Sell(0)

Neutral(0)

Buy(6)

Indicators

Value

Direction

MA5

0.130

Buy

MA10

0.158

Buy

MA20

0.194

Buy

MA50

0.198

Buy

MA100

0.205

Buy

MA200

0.193

Buy

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Sunshine Biopharma, Inc. is a Canada-based pharmaceutical company. The Company offers and researches life-saving medicines in a variety of therapeutic areas, including oncology and antivirals. The Company has over 32 additional generic prescription drugs. In addition, the Company is conducting a proprietary drug development program which consists of K1.1 mRNA, an mRNA-Lipid Nanoparticle targeted for liver cancer, and PLpro protease inhibitor, a small molecule for treatment of SARS Coronavirus infections. The Company operates through two segments: Prescription Generic Pharmaceuticals (Generic Pharmaceuticals) and Nonprescription Over-The-Counter Products (OTC Products). It also operates two wholly owned subsidiaries: NoraPharma Inc., which has a portfolio of pharmaceutical products consisting of approximately 61 generic prescription drugs on the market in Canada, and Sunshine Biopharma Canada Inc., which develops and sells non-prescription over-the-counter (OTC) products.

Ticker SymbolSBFMW

CompanySunshine Biopharma Inc

CEODr. Steve N. Slilaty

Websitehttps://www.sunshinebiopharma.com/